NANOG and cancer: Treatment with PtCl2(S-pr-thiosal)2 also reduced the expression of phosphorylated STAT3 and downstream-regulated molecules associated with cancer stemness and proliferation, NANOG, cyclin D3, and c-Myc, and the expression of phosphorylated NFκB in vitro and in vivo.